Examination of multidrug resistance in cell lines and primary breast tumours by flow cytometry
- 31 December 1996
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 32 (13) , 2334-2341
- https://doi.org/10.1016/s0959-8049(96)00344-9
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Use of the biotinylated antibody DAKO‐ER 1D5 to measure oestrogen receptor on cytokeratin positive cells obtained from primary breast cancer cellsCytometry, 1995
- Flow cytometric method for the measurement of epidermal growth factor receptor and comparison with the radio‐ligand binding assayCytometry, 1994
- P-glycoprotein expression in locally advanced breast cancer treated by neoadjuvant chemotherapyBritish Journal of Cancer, 1992
- P-glycoprotein expression in primary breast cancer detected by immunocytochemistry with two monoclonal antibodiesBritish Journal of Cancer, 1990
- Quantitative Determination of Factors Contributing to Doxorubicin Resistance in Multidrug-Resistant CellsJNCI Journal of the National Cancer Institute, 1989
- THE BIOCHEMISTRY OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG RESISTANCEAnnual Review of Biochemistry, 1989
- Expression of Multidrug Resistance Gene in Human CancersJNCI Journal of the National Cancer Institute, 1989
- Monoclonal antibody JSB‐1 detects a highly conserved epitope on the P‐glycoprotein associated with multi‐drug‐resistanceInternational Journal of Cancer, 1988
- Immunocytochemical localization of P170 at the plasma membrane of multidrug-resistant human cells.Journal of Histochemistry & Cytochemistry, 1987
- Cell Surface P-Glycoprotein Associated with Multidrug Resistance in Mammalian Cell LinesScience, 1983